Highest-materiality recent filing
Completed IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
Oaktree Acquisition Corp. III Life Sciences prices $175M IPO at $10/unit
Gross proceeds of $175M from 17.5M units at $10.00 each; units trade on Nasdaq as OACCU.
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
On January 6, 2025, John Frank resigned from the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”).
the Board appointed (i) Aman Kumar, currently a director of the Company, as the new chairman of the Board
and (ii) Zaid Pardesi, the Company’s Chief Executive Officer, as a director of the Company.
Max materiality 0.70 · Median 0.50 · Most common event leadership